About Polarean Imaging
Polarean Imaging is a company based in Durham (United States) founded in 2012 by Bastiaan Driehuys. Polarean Imaging offers products and services including Xenon MRI Platform, HPX Hyperpolarizer, HPX Measurement Station, HPX Gas Manifold, and Chest Coil. Polarean Imaging operates in a competitive market with competitors including Imbio, Tomophase, Fluidda, Bioxydyn and Cyclopharm, among others.
- Headquarter Durham, United States
- Founders Bastiaan Driehuys
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Polarean Imaging Plc
-
Annual Revenue
$3.03 M (USD)237.39as on Dec 31, 2024
-
Net Profit
-$8.37 M (USD)30.1as on Dec 31, 2024
-
EBITDA
-$7.63 M (USD)34.83as on Dec 31, 2024
-
Latest Funding Round
$10 M (USD), Post-IPO
May 22, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Polarean Imaging
Polarean Imaging is a publicly listed company on the LSE with ticker symbol POLX in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Polarean Imaging
Polarean Imaging offers a comprehensive portfolio of products and services, including Xenon MRI Platform, HPX Hyperpolarizer, HPX Measurement Station, HPX Gas Manifold, and Chest Coil.
Platform for non-invasive lung function imaging using xenon gas.
Device that produces high-purity hyperpolarized xenon for MRI use.
System for calibrating polarization levels in hyperpolarized gas.
Equipment for regulating and purifying xenon gas blends for imaging.
Specialized coil designed for Xenon MRI lung scans.
People of Polarean Imaging
Unlock access to complete
Unlock access to complete
Funding Insights of Polarean Imaging
Investors in Polarean Imaging
Polarean Imaging has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Polarean Imaging
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Polarean Imaging
Investment portfolio details for Polarean Imaging
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Polarean Imaging
Detailed financials for Polarean Imaging
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Polarean Imaging Comparisons
Peer comparison for Polarean Imaging
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Polarean Imaging
Polarean Imaging operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbio, Tomophase, Fluidda, Bioxydyn and Cyclopharm, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical imaging analysis for respiratory clinical support is provided.
|
|
| Locked | Locked | Locked |
Endoscopic devices for respiratory disorders are developed using optical interferometry.
|
|
| Locked | Locked | Locked |
Functional respiratory imaging and contract research services are provided.
|
|
| Locked | Locked | Locked |
MRI-based diagnostic imaging services for respiratory disorders are offered.
|
|
| Locked | Locked | Locked |
Medical devices and radiopharmaceuticals for lung imaging are developed.
|
Detailed competitors of Polarean Imaging
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Polarean Imaging
Complete news archive for Polarean Imaging
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polarean Imaging
Polarean Imaging was founded in 2012.
Polarean Imaging is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Richard Hullihen is the current CEO of Polarean Imaging.
Annual revenue of Polarean Imaging is $3.03M as on Dec 31, 2024.
Polarean Imaging provides noble gas polarizer devices and ancillary instruments. The company manufactures and provides services for noble gas polarizer devices and ancillary instruments with a focus on pulmonary imaging using hyperpolarized gas MRI. Diseases like COPD, cystic fibrosis, asthma can be diagnosed with this MRI. It also helps during stent placement and radiotherapy. The product offered by the company includes xenon-129 and helium-3 polarizers, polarization measurement stations and upgrade kits for existing polarizers.
Polarean Imaging offers Xenon MRI Platform, HPX Hyperpolarizer, HPX Measurement Station, HPX Gas Manifold, and Chest Coil.
Yes, Polarean Imaging is publicly traded on LSE under the ticker symbol POLX.
Polarean Imaging has 1 investor. Key investors include HHS.
The ticker symbol of Polarean Imaging is POLX on LSE.